According to the “Catalogue of Classification Management of Fixed Pollution Sources for Pollution Discharges” issued in 2017, raw material drug manufacturers should obtain sewage discharge permits by the end of 2017. The 11 raw material drug manufacturers under Shanghai Pharmaceuticals all obtained sewage discharge permits on schedule. According to the requirements of the environmental protection department, the company’s 13 pharmaceutical production companies have also completed the VOC rectification and acceptance.
According to the company’s disclosure, the annual energy-saving target issued by Shanghai Economic and Information Commission to Shanghai Pharmaceuticals is that the comprehensive energy consumption in 2017 will be 125,000 tons of standard coal. Upon enquiry, Shanghai Pharmaceuticals actually completed the energy consumption of 119,500 tons of standard coal in 2017, successfully completing the energy-saving tasks issued by the government. The above-mentioned company said that the emphasis on environmental protection reflects the company’s level of governance, and the investment in environmental protection is also the embodiment of the company’s comprehensive strength.
Shanghai Leiyunshang Pharmaceutical Co., Ltd., the core asset of Shanghai Pharmaceuticals Co., Ltd., invested a total of 2.15 million yuan in 2017. The reporter noted that through the renovation of energy-using equipment, its 2017 output increased by 20% year-on-year, electricity consumption decreased by 3.5% compared with last year, natural gas consumption decreased by 7.6% compared with last year, and gasoline consumption decreased by 13% compared with last year. Last year, it fell by 15%.